BULLISHWHALES
BullishWhales · Congress · Trade Detail
NASDAQ: PCRXPacira BioSciences, Inc.
DemocratHouse

Tom Malinowski bought Pacira BioSciences, Inc. (NASDAQ: PCRX)

Tom Malinowski (D-NJ), a U.S. Representative, has disclosed 11 trades in Pacira BioSciences, Inc. (PCRX) since 2019, all purchases, worth an estimated $211K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Tom Malinowski bought $1,001 - $15,000 of Pacira BioSciences, Inc. (NASDAQ: PCRX) on January 25, 2021. Since that trade, PCRX is down -63.50% against the S&P 500 up +110.98%, an outperformance of -174.47%.

Across these filings, Tom Malinowski has been a net buyer of PCRX. The most recent disclosed PCRX transaction shown was dated May 6, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PCRX trades
11
Disclosed Vol
$211K
Buys
11
100%
Sells
0
0%
Buy / Sell
All buys
ratio
First → Last
2019–2021

Tom Malinowski's PCRX trades vs the price

PCRX is down -63.50% since Tom Malinowski bought on January 25, 2021, versus +110.98% for the S&P 500.

Performance since this trade

Price change since trade
-63.50%
S&P 500 change since trade
+110.98%
Outperformance vs S&P 500
-174.47%

All Tom Malinowski PCRX trades

TradedTypeSizeReturnEst. profit
May 6, 2021BUY$63.21-59.69%-$5K
April 20, 2021BUY$62.65-59.33%-$5K
January 25, 2021BUY$69.80-63.50%-$5K
January 15, 2021BUY$73.68-65.42%-$5K
November 2, 2020BUY$52.57-51.53%-$4K
September 26, 2019BUY$39.85-36.06%-$12K
August 23, 2019BUY$36.54-30.27%-$2K
May 31, 2019BUY$43.51-41.44%-$13K
May 31, 2019BUY$43.51-41.44%-$13K
May 30, 2019BUY$44.46-42.69%-$14K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Tom Malinowski & PCRX trading FAQ

Is it legal for Tom Malinowski to trade Pacira BioSciences, Inc. (PCRX) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Pacira BioSciences, Inc. (PCRX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did Tom Malinowski buy PCRX?

Tom Malinowski disclosed a purchase of $1,001 - $15,000 of Pacira BioSciences, Inc. (PCRX) on January 25, 2021, according to public STOCK Act filings.

How has PCRX performed since Tom Malinowski's trade?

Since Tom Malinowski bought PCRX on January 25, 2021, the stock is down -63.50%, versus +110.98% for the S&P 500 over the same period, an outperformance of -174.47%.

How many times has Tom Malinowski traded PCRX?

Tom Malinowski has disclosed 11 PCRX trades since 2019. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PCRX trades?

BullishWhales tracks every disclosed congressional trade in Pacira BioSciences, Inc. (PCRX) on the Pacira BioSciences, Inc. congressional trading page, which aggregates filings across all members of Congress.

Tom Malinowski's PCRX tradesAll congressional filings for Pacira BioSciences, Inc.Tom Malinowski's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30